EXPERIMENTAL STUDY OF N-(γ-AMINOBUTYRYL)-1-AZA-4,7,10,13-TETRAOXACYCLOPENTADECANE HYDROCHLORIDE ANALGESIC ACTIVITY IN PAIN SYNDROMES OF DIFFERENT ETIOLOGY-Reference-Cited by-同舟云学术

EXPERIMENTAL STUDY OF N-(γ-AMINOBUTYRYL)-1-AZA-4,7,10,13-TETRAOXACYCLOPENTADECANE HYDROCHLORIDE ANALGESIC ACTIVITY IN PAIN SYNDROMES OF DIFFERENT ETIOLOGY

Published:2024 Issue:87 Volume:20 Page:187
ISSN:2079-8334
Container-title:World of Medicine and Biology
language:en
Short-container-title:WOMAB

Author:

Voloshchuk N. I.¹,Orlenko O. B.¹,Petrushenko V. V.¹,Basok S. S.²,Larionov V. B.²,Golovenko M. Ya.²

Affiliation:

1. National Pirogov Memorial Medical University

2. A.V. Bogatsky Physico-Chemical Institute

Publisher

Scientific Society Anatomists, Histologists, and Embryologists, Ukraine

Reference15 articles.

1. Bohatskyi OV, Lukianenko MH, Voronina TO, ta in. vynakhidnyky N-(γ-aminobutyryl)-1-aza-4,7,10,13-tetraoksatsyklopentadekan hidrokhloryd, shcho maye antyamnestychnu, antyhipoksychnu ta protysudomnu aktyvnist. Patent 7121 Ukraina, MKY S 07 D 273/01. 1995 Cher 30. [in Ukrainian]

2. Holovenko MIa. Rol pokhidnykh 1,4-benzodiazepinu ta sporidnenykh spoluk u vyvchenni morfofunktsionalnoyi orhanizatsiyi neiroretseptoriv HAMK (ohliad literatury). Farmakolohiya ta likarska toksykolohiya. 2020; 14(6): 375–388. doi: https://doi.org/10.33250/14.06.375. [in Ukrainian]

3. Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021 May 29;397(10289):2082–2097. doi: 10.1016/S0140-6736(21)00393-7.

4. Cook DC, Goldstein PA. Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels. Curr Neuropharmacol. 2021 Oct 1;19(11):1937–1951. doi: https://doi.org/10.2174/1570159X19666210119153047.

5. Domenichiello AF, Ramsden CE. The silent epidemic of chronic pain in older adults. Prog Neuro-psychopharmacol Biol Psychiatry. 2019 Jul 13;93: 284–290. doi: https://doi.org/10.1016/j.pnpbp.2019.04.006.